Leap Therapeutics Files 2025 Proxy Statement
Ticker: CYPH · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1509745
| Field | Detail |
|---|---|
| Company | Leap Therapeutics, INC. (CYPH) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Leap Therapeutics DEF 14A filed. Annual meeting June 18. Vote your shares!
AI Summary
Leap Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting of stockholders scheduled for June 18, 2025. The filing details the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, executive pay, and voting matters, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing for an annual meeting, not indicating new material risks.
Key Numbers
- 20250618 — Annual Meeting Date (Shareholders will vote on company matters on this date.)
- 20250428 — Filing Date (The proxy statement was filed with the SEC on this date.)
Key Players & Entities
- LEAP THERAPEUTICS, INC. (company) — Registrant
- 0001104659-25-039607 (filing_id) — Accession Number
- 20250428 (date) — Filing Date
- 20250618 (date) — Meeting Date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the upcoming annual meeting on June 18, 2025, including details on director nominations, executive compensation, and other corporate matters requiring a shareholder vote.
When is Leap Therapeutics' annual meeting of stockholders scheduled?
The annual meeting of stockholders is scheduled for June 18, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed with the SEC on April 28, 2025.
What is the company's Central Index Key (CIK)?
Leap Therapeutics, Inc.'s Central Index Key (CIK) is 0001509745.
What is the company's Standard Industrial Classification (SIC) code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding LEAP THERAPEUTICS, INC. (CYPH).